Healthy Returns: The launch of breakthrough Alzheimer's drug Leqembi is off to a slow start

The Alzheimer’s drug Leqembi from Biogen and Eisai is seeing a slow launch, but demand is rising. Meanwhile, headsets are making some users nauseous.

Related Keywords

California ,United States ,New York ,Japan ,Americans ,Japanese ,Jim Cramer ,Natascha Tuznik ,Eli Lilly ,Joanna Jen ,Todd Haselton ,Tim Cook ,Chris Viehbacher ,Morgan Stanley ,Drug Administration ,Mount Sinai Health System ,University Of California ,Wall Street ,Vision Pro ,News ,